Rituximab and risk of COVID-19 infection and its severity in patients with MS and NMOSD.
Esmaeili S, Abbasi MH, Abolmaali M, Mojtahed M, Alavi SNR, Soleimani S, Mokhtari M, Hatam J, Khotbehsara ST, Motamed MR, Joghataei MT, Mirzaasgari Z, Moghaddasi M.
Esmaeili S, et al. Among authors: hatam j.
BMC Neurol. 2021 May 1;21(1):183. doi: 10.1186/s12883-021-02218-4.
BMC Neurol. 2021.
PMID: 33933026
Free PMC article.